José Ricardo Magliocco Ceroni
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
José Ricardo Magliocco Ceroni has a total of 130 co-authors. Here are the top co-authors by number of shared publications:
- Alexandre Torchio Dias
Laboratório de Citogenética, Serviço de Laboratório de Análises Clínicas, Instituto de Assistência Médica do Servidor Público do Estado de São Paulo (IAMSPE), São Paulo, Brasil
2 shared publications - Anne Caroline Barbosa
Hospital Israelita Albert Einstein
2 shared publications - Bianca Bianco
Centro Universitário FMABC, Santo Andre, SP, Brazil
2 shared publications - Caio Parente Barbosa
Postgraduate Program in Health Sciences, Centro Universitário FMABC, Santo André, Brazil
2 shared publications - Caio Robledo D' Angioli Costa Quaio
Hospital Israelita Albert Einstein, São Paulo, Brazil
2 shared publications - Carolina Araujo Moreno
Hospital Israelita Albert Einstein
2 shared publications
Latest Publications
- Open Access
ACMG Secondary Findings in the Brazilian Rare Genomes Project: Insights from 5,402 genome sequencing
Purpose: Secondary findings (SF) are pathogenic or likely pathogenic variants in genes unrelated to the primary purpose of genetic testing. The American College of Medical Genetics (ACMG) provides guidelines on which SF should be reported, involving 81 genes linked to different conditions. With the increasing use of genome sequencing (GS), SF are more frequently detected, presenting challenges for healthcare systems. The Brazilian population is often underrepresented in genomic studies, which limits population-specific knowledge. Objective: This study aimed to outline the profile of SF in the Brazilian Rare Genomes Project (BRGP). Methods: We analyzed retrospectively SF (ACMG) data from GS of 5,402 BRGP individuals. Results: Of the 5,316 cases who consented to receive SF, 3.6% (191 cases) had at least one SF. The most common genes identified were TTR, TTN, and BRCA2 . SF were mainly related to cardiovascular conditions (40.2%) and cancer predisposition (37.6%). Some variants, such as TTR: c.424G>A; p. (Val142Ile) and TP53: c.1010G>A; p. (Arg337His), were recurrent, reflecting population-specific traits and founder effects. Novel variants were 10.6% of SF. Conclusion: SF rate varies across studies and populations. While SF can aid early diagnosis, their relevance is debated due to potential psychological and healthcare burdens. Effective genetic counseling and public health policies are essential.
Open AccessACMG Secondary Findings in the Brazilian Rare Genomes Project: Insights from 5,402 genome sequencing
Purpose: Secondary findings (SF) are pathogenic or likely pathogenic variants in genes unrelated to the primary purpose of genetic testing. The American College of Medical Genetics (ACMG) provides guidelines on which SF should be reported, involving 81 genes linked to different conditions. With the increasing use of genome sequencing (GS), SF are more frequently detected, presenting challenges for healthcare systems. The Brazilian population is often underrepresented in genomic studies, which limits population-specific knowledge. Objective: This study aimed to outline the profile of SF in the Brazilian Rare Genomes Project (BRGP). Methods: We analyzed retrospectively SF (ACMG) data from GS of 5,402 BRGP individuals. Results: Of the 5,316 cases who consented to receive SF, 3.6% (191 cases) had at least one SF. The most common genes identified were TTR, TTN, and BRCA2 . SF were mainly related to cardiovascular conditions (40.2%) and cancer predisposition (37.6%). Some variants, such as TTR: c.424G>A; p. (Val142Ile) and TP53: c.1010G>A; p. (Arg337His), were recurrent, reflecting population-specific traits and founder effects. Novel variants were 10.6% of SF. Conclusion: SF rate varies across studies and populations. While SF can aid early diagnosis, their relevance is debated due to potential psychological and healthcare burdens. Effective genetic counseling and public health policies are essential.
- Open Access
- 15 January 2024
- Published by Revista de Epidemiologia e Saúde Pública in Revista de Epidemiologia e Saúde Pública - RESP
- Vol. 2 (1)
PREIMPLANTATION GENETIC DIAGNOSIS FOR HUNTINGTON’S DISEASE - CASE REPORT AND LITERATURE REVIEW
Background: Huntington’s disease is a rare, neurodegenerative, autosomal dominant disorder with adult onset caused by an expansion of 36 or more CAG trinucleotide repeats in the HTT gene. In Brazil and in some other countries, carriers of HTT’s expanded allele of submitted to in vitro fertilization procedure can investigate embryos genetically to identify the ones that have inherited the expanded allele and the ones that inherited only the normal size alleles. In some instances, an individual has a positive familial history for the disease and do not want to know his/her personal carrier status but is willing to conceive children without the disease. Objective: to demonstrate the reproductive possibilities available to patients with Huntington disease through a case report and literature review. Methods: Here, we discussed the application and viability of the genetic screening techniques, based on a non-disclosure case of Preimplantation Genetic Testing (PGT). Results: a couple submitted to a non-disclosure test for Huntington disease was submitted to IVF, embryo biopsy and genetic analysis of the samples due to a familial history of the condition. Chromosome and mutation specific tests were applied, and one embryo was selected for uterine transfer. The couple was not informed why the other embryos were discharged. Conclusion: Although many ethical and practical aspects are involved in this decision, a non-disclosure PGT can be offered as an option for these couples, besides sperm, egg or embryo adoption, or child adoption.
- 15 January 2024
- Published by Revista de Epidemiologia e Saúde Pública in Revista de Epidemiologia e Saúde Pública - RESP
- Vol. 2 (1)
Open AccessPREIMPLANTATION GENETIC DIAGNOSIS FOR HUNTINGTON’S DISEASE - CASE REPORT AND LITERATURE REVIEW
Background: Huntington’s disease is a rare, neurodegenerative, autosomal dominant disorder with adult onset caused by an expansion of 36 or more CAG trinucleotide repeats in the HTT gene. In Brazil and in some other countries, carriers of HTT’s expanded allele of submitted to in vitro fertilization procedure can investigate embryos genetically to identify the ones that have inherited the expanded allele and the ones that inherited only the normal size alleles. In some instances, an individual has a positive familial history for the disease and do not want to know his/her personal carrier status but is willing to conceive children without the disease. Objective: to demonstrate the reproductive possibilities available to patients with Huntington disease through a case report and literature review. Methods: Here, we discussed the application and viability of the genetic screening techniques, based on a non-disclosure case of Preimplantation Genetic Testing (PGT). Results: a couple submitted to a non-disclosure test for Huntington disease was submitted to IVF, embryo biopsy and genetic analysis of the samples due to a familial history of the condition. Chromosome and mutation specific tests were applied, and one embryo was selected for uterine transfer. The couple was not informed why the other embryos were discharged. Conclusion: Although many ethical and practical aspects are involved in this decision, a non-disclosure PGT can be offered as an option for these couples, besides sperm, egg or embryo adoption, or child adoption.
- Open Access
- 16 November 2023
- Published by Springer Nature in Human Genomics
- Vol. 17 (1) , 1-15
The hospital Israelita Albert Einstein standards for constitutional sequence variants classification: version 2023
Background: Next-generation sequencing has had a significant impact on genetic disease diagnosis, but the interpretation of the vast amount of genomic data it generates can be challenging. To address this, the American College of Medical Genetics and Genomics and the Association for Molecular Pathology have established guidelines for standardized variant interpretation. In this manuscript, we present the updated Hospital Israelita Albert Einstein Standards for Constitutional Sequence Variants Classification, incorporating modifications from leading genetics societies and the ClinGen initiative. Results: First, we standardized the scientific publications, documents, and other reliable sources for this document to ensure an evidence-based approach. Next, we defined the databases that would provide variant information for the classification process, established the terminology for molecular findings, set standards for disease-gene associations, and determined the nomenclature for classification criteria. Subsequently, we defined the general rules for variant classification and the Bayesian statistical reasoning principles to enhance this process. We also defined bioinformatics standards for automated classification. Our workgroup adhered to gene-specific rules and workflows curated by the ClinGen Variant Curation Expert Panels whenever available. Additionally, a distinct set of specifications for criteria modulation was created for cancer genes, recognizing their unique characteristics. Conclusions: The development of an internal consensus and standards for constitutional sequence variant classification, specifically adapted to the Brazilian population, further contributes to the continuous refinement of variant classification practices. The aim of these efforts from the workgroup is to enhance the reliability and uniformity of variant classification.
- 16 November 2023
- Published by Springer Nature in Human Genomics
- Vol. 17 (1) , 1-15
Open AccessThe hospital Israelita Albert Einstein standards for constitutional sequence variants classification: version 2023
Background: Next-generation sequencing has had a significant impact on genetic disease diagnosis, but the interpretation of the vast amount of genomic data it generates can be challenging. To address this, the American College of Medical Genetics and Genomics and the Association for Molecular Pathology have established guidelines for standardized variant interpretation. In this manuscript, we present the updated Hospital Israelita Albert Einstein Standards for Constitutional Sequence Variants Classification, incorporating modifications from leading genetics societies and the ClinGen initiative. Results: First, we standardized the scientific publications, documents, and other reliable sources for this document to ensure an evidence-based approach. Next, we defined the databases that would provide variant information for the classification process, established the terminology for molecular findings, set standards for disease-gene associations, and determined the nomenclature for classification criteria. Subsequently, we defined the general rules for variant classification and the Bayesian statistical reasoning principles to enhance this process. We also defined bioinformatics standards for automated classification. Our workgroup adhered to gene-specific rules and workflows curated by the ClinGen Variant Curation Expert Panels whenever available. Additionally, a distinct set of specifications for criteria modulation was created for cancer genes, recognizing their unique characteristics. Conclusions: The development of an internal consensus and standards for constitutional sequence variant classification, specifically adapted to the Brazilian population, further contributes to the continuous refinement of variant classification practices. The aim of these efforts from the workgroup is to enhance the reliability and uniformity of variant classification.
- Open Access
Whole-genome sequencing of 1,171 elderly admixed individuals from the largest Latin American metropolis (São Paulo, Brazil)
As whole-genome sequencing (WGS) becomes the gold standard tool for studying population genomics and medical applications, data on diverse non-European and admixed individuals are still scarce. Here, we present a high-coverage WGS dataset of 1,171 highly admixed elderly Brazilians from a census-based cohort, providing over 76 million variants, of which ~2 million are absent from large public databases. WGS enabled identifying ~2,000 novel mobile element insertions, nearly 5Mb of genomic segments absent from human genome reference, and over 140 novel alleles from HLA genes. We reclassified and curated nearly four hundred variant's pathogenicity assertions in genes associated with dominantly inherited Mendelian disorders and calculated the incidence for selected recessive disorders, demonstrating the clinical usefulness of the present study. Finally, we observed that whole-genome and HLA imputation could be significantly improved compared to available datasets since rare variation represents the largest proportion of input from WGS. These results demonstrate that even smaller sample sizes of underrepresented populations bring relevant data for genomic studies, especially when exploring analyses allowed only by WGS.
Open AccessWhole-genome sequencing of 1,171 elderly admixed individuals from the largest Latin American metropolis (São Paulo, Brazil)
As whole-genome sequencing (WGS) becomes the gold standard tool for studying population genomics and medical applications, data on diverse non-European and admixed individuals are still scarce. Here, we present a high-coverage WGS dataset of 1,171 highly admixed elderly Brazilians from a census-based cohort, providing over 76 million variants, of which ~2 million are absent from large public databases. WGS enabled identifying ~2,000 novel mobile element insertions, nearly 5Mb of genomic segments absent from human genome reference, and over 140 novel alleles from HLA genes. We reclassified and curated nearly four hundred variant's pathogenicity assertions in genes associated with dominantly inherited Mendelian disorders and calculated the incidence for selected recessive disorders, demonstrating the clinical usefulness of the present study. Finally, we observed that whole-genome and HLA imputation could be significantly improved compared to available datasets since rare variation represents the largest proportion of input from WGS. These results demonstrate that even smaller sample sizes of underrepresented populations bring relevant data for genomic studies, especially when exploring analyses allowed only by WGS.
- Open Access
- 30 September 2019
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 8 (2) , e957
Breakpoint delineation in 5p‐ patients leads to new insights about microcephaly and the typical high‐pitched cry
Background: Cri du chat syndrome (CdCS) is a rare syndrome caused by a partial or complete deletion of the short arm of chromosome 5 (5p‐). The main clinical features include a high‐pitched cry, facial asymmetry, microcephaly, round face at birth, epicanthal folds, hypotonia, delayed growth and development.Methods: We studied 14 Brazilian patients with CdCS using genomic array in order to better define the 5p breakpoints and recognize copy number variations (CNVs) that contribute to clinical manifestations associated with the syndrome.Results: Array confirmed terminal deletions in 13 patients and an interstitial deletion in one patient. It was also possible to map the breakpoints and associate a genomic region of 4.7 Mb to the development of head circumference and cat‐like cry. We also found other CNVs concomitant to the 5p deletion including a 9p duplication, a 17q deletion, and a 22q deletion in three different patients.Conclusion: With advancements of molecular cytogenomic methods in the last two decades, it was possible to evidence cryptic alterations and improve the genotype–phenotype correlation. In this work, we describe a new genomic region associated with microcephaly and cat‐like cry and highlight the importance of precise delineation of 5p deletion breakpoints and detection of other CNVs in CdCS patients to improve genotype–phenotype correlation to perform a complete clinical and molecular diagnosis.
- 30 September 2019
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 8 (2) , e957
Open AccessBreakpoint delineation in 5p‐ patients leads to new insights about microcephaly and the typical high‐pitched cry
Background: Cri du chat syndrome (CdCS) is a rare syndrome caused by a partial or complete deletion of the short arm of chromosome 5 (5p‐). The main clinical features include a high‐pitched cry, facial asymmetry, microcephaly, round face at birth, epicanthal folds, hypotonia, delayed growth and development.Methods: We studied 14 Brazilian patients with CdCS using genomic array in order to better define the 5p breakpoints and recognize copy number variations (CNVs) that contribute to clinical manifestations associated with the syndrome.Results: Array confirmed terminal deletions in 13 patients and an interstitial deletion in one patient. It was also possible to map the breakpoints and associate a genomic region of 4.7 Mb to the development of head circumference and cat‐like cry. We also found other CNVs concomitant to the 5p deletion including a 9p duplication, a 17q deletion, and a 22q deletion in three different patients.Conclusion: With advancements of molecular cytogenomic methods in the last two decades, it was possible to evidence cryptic alterations and improve the genotype–phenotype correlation. In this work, we describe a new genomic region associated with microcephaly and cat‐like cry and highlight the importance of precise delineation of 5p deletion breakpoints and detection of other CNVs in CdCS patients to improve genotype–phenotype correlation to perform a complete clinical and molecular diagnosis.
- Open Access
- 8 June 2019
- Published by Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein in Einstein (São Paulo)
- Vol. 17 (3) , eRC4577
Reproductive alternatives for patients with dystrophic epidermolysis bullosa
Epidermolysis bullosa describes a group of skin conditions caused by mutations in genes encoding proteins related to dermal-epidermal adhesion. In the United States, 50 cases of epidermolysis bullosa per 1 million live births are estimated, 92% of which classified as simplex, 5% dystrophic, 1% junctional and 2% non-classified. Dystrophic epidermolysis bullosa is associated with autosomal, dominant and recessive inheritance. Epidermolysis bullosa causes severe psychological, economic and social impacts, and there is currently no curative therapy, only symptom control. Embryonic selection is available for epidermolysis bullosa patients in order to prevent perpetuation of the condition in their offspring.
- 8 June 2019
- Published by Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein in Einstein (São Paulo)
- Vol. 17 (3) , eRC4577
Open AccessReproductive alternatives for patients with dystrophic epidermolysis bullosa
Epidermolysis bullosa describes a group of skin conditions caused by mutations in genes encoding proteins related to dermal-epidermal adhesion. In the United States, 50 cases of epidermolysis bullosa per 1 million live births are estimated, 92% of which classified as simplex, 5% dystrophic, 1% junctional and 2% non-classified. Dystrophic epidermolysis bullosa is associated with autosomal, dominant and recessive inheritance. Epidermolysis bullosa causes severe psychological, economic and social impacts, and there is currently no curative therapy, only symptom control. Embryonic selection is available for epidermolysis bullosa patients in order to prevent perpetuation of the condition in their offspring.
- 2 February 2019
- Published by Springer Nature in Skeletal Radiology
- Vol. 48 (8) , 1201-1207
Clinical and radiological findings in Brazilian patients with mucolipidosis types II/III
The present study aims to provide orientation for clinicians and radiologists to recognize the most prevalent findings leading to diagnosis in mucolipidosis from a description of the natural history of five Brazilian cases.
- 2 February 2019
- Published by Springer Nature in Skeletal Radiology
- Vol. 48 (8) , 1201-1207
Clinical and radiological findings in Brazilian patients with mucolipidosis types II/III
The present study aims to provide orientation for clinicians and radiologists to recognize the most prevalent findings leading to diagnosis in mucolipidosis from a description of the natural history of five Brazilian cases.
- Open Access
- 6 September 2018
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 13382
A Multicentric Brazilian Investigative Study of Copy Number Variations in Patients with Congenital Anomalies and Intellectual Disability
Genomic imbalances are the most common cause of congenital anomalies (CA) and intellectual disability (ID). The aims of this study were to identify copy number variations (CNVs) in 416 patients with CA and ID from 5 different genetics centers within 4 different states by using the Multiplex Ligation-dependent Probe Amplification (MLPA) technique and to apply the chromosomal microarray (CMA) methodology in selected cases. The samples were analyzed by MLPA kits P064, P036, P070 and P250. Positive results were found in 97/416 (23.3%) patients. CMA was applied in 14 selected cases. In 6/14 (42.85%) patients, CMA detected other copy number variations not detected by the MLPA studies. Although CMA is indispensable for genotype refinement, the technique is still unfeasible in some countries as a routine analysis due to economic and technical limitations. In these cases, clinical evaluation followed by karyotyping and MLPA analysis is a helpful and affordable solution for diagnostic purposes.
- 6 September 2018
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 13382
Open AccessA Multicentric Brazilian Investigative Study of Copy Number Variations in Patients with Congenital Anomalies and Intellectual Disability
Genomic imbalances are the most common cause of congenital anomalies (CA) and intellectual disability (ID). The aims of this study were to identify copy number variations (CNVs) in 416 patients with CA and ID from 5 different genetics centers within 4 different states by using the Multiplex Ligation-dependent Probe Amplification (MLPA) technique and to apply the chromosomal microarray (CMA) methodology in selected cases. The samples were analyzed by MLPA kits P064, P036, P070 and P250. Positive results were found in 97/416 (23.3%) patients. CMA was applied in 14 selected cases. In 6/14 (42.85%) patients, CMA detected other copy number variations not detected by the MLPA studies. Although CMA is indispensable for genotype refinement, the technique is still unfeasible in some countries as a routine analysis due to economic and technical limitations. In these cases, clinical evaluation followed by karyotyping and MLPA analysis is a helpful and affordable solution for diagnostic purposes.
- Open Access
- 19 February 2018
- Published by FapUNIFESP (SciELO) in Genetics and Molecular Biology
- Vol. 41 (1) , 85-91
Large deletion in PIGL: a common mutational mechanism in CHIME syndrome?
CHIME syndrome is an extremely rare autosomal recessive multisystemic disorder caused by mutations in PIGL. PIGL is an endoplasmic reticulum localized enzyme that catalyzes the second step of glycosylphosphatidylinositol (GPI) biosynthesis, which plays a role in the anchorage of cell-surface proteins including receptors, enzymes, and adhesion molecules. Germline mutations in other members of GPI and Post GPI Attachment to Proteins (PGAP) family genes have been described and constitute a group of diseases within the congenital disorders of glycosylation. Patients in this group often present alkaline phosphatase serum levels abnormalities and neurological symptoms. We report a CHIME syndrome patient who harbors a missense mutation c.500T > C (p.Leu167Pro) and a large deletion involving the 5’ untranslated region and part of exon 1 of PIGL. In CHIME syndrome, a recurrent missense mutation c.500T > C (p.Leu167Pro) is found in the majority of patients, associated with a null mutation in the other allele, including an overrepresentation of large deletions. The latter are not detected by the standard analysis in sequencing techniques, including next-generation sequencing. Thus, in individuals with a clinical diagnosis of CHIME syndrome in which only one mutation is found, an active search for a large deletion should be sought.
- 19 February 2018
- Published by FapUNIFESP (SciELO) in Genetics and Molecular Biology
- Vol. 41 (1) , 85-91
Open AccessLarge deletion in PIGL: a common mutational mechanism in CHIME syndrome?
CHIME syndrome is an extremely rare autosomal recessive multisystemic disorder caused by mutations in PIGL. PIGL is an endoplasmic reticulum localized enzyme that catalyzes the second step of glycosylphosphatidylinositol (GPI) biosynthesis, which plays a role in the anchorage of cell-surface proteins including receptors, enzymes, and adhesion molecules. Germline mutations in other members of GPI and Post GPI Attachment to Proteins (PGAP) family genes have been described and constitute a group of diseases within the congenital disorders of glycosylation. Patients in this group often present alkaline phosphatase serum levels abnormalities and neurological symptoms. We report a CHIME syndrome patient who harbors a missense mutation c.500T > C (p.Leu167Pro) and a large deletion involving the 5’ untranslated region and part of exon 1 of PIGL. In CHIME syndrome, a recurrent missense mutation c.500T > C (p.Leu167Pro) is found in the majority of patients, associated with a null mutation in the other allele, including an overrepresentation of large deletions. The latter are not detected by the standard analysis in sequencing techniques, including next-generation sequencing. Thus, in individuals with a clinical diagnosis of CHIME syndrome in which only one mutation is found, an active search for a large deletion should be sought.
- Open Access
Natural history of 39 patients with Achondroplasia
To characterize the natural history of 39 achondroplastic patients diagnosed by clinical, radiological and molecular assessments.Observational and retrospective study of 39 patients who were attended at a public tertiary level hospital between 1995 and ...
Open AccessNatural history of 39 patients with Achondroplasia
To characterize the natural history of 39 achondroplastic patients diagnosed by clinical, radiological and molecular assessments.Observational and retrospective study of 39 patients who were attended at a public tertiary level hospital between 1995 and ...